Abstract:Background
Secondary polycythemia is associated with cigarette smoking and chronic obstructive pulmonary disease (COPD). However, the prevalence of polycythemia in COPD and the contributing risk factors for polycythemia in COPD have not been extensively studied.
Methods
We analyzed the presence of secondary polycythemia in current and former smokers with moderate to very severe COPD at the five-year follow-up visit in the observational COPDGene stu… Show more
“…4 Zhang et al found that 6.6% of COPD patients met the diagnostic criteria for polycythemia with a cutoff of Hb >165 g/L in males and >160 g/L in females and suggested that race and altitude have an impact on the prevalence of polycythemia. 20 In our study, the prevalence of polycythemia was only 3.9%, which might be because all our patients lived at high altitudes and ethnic groups other than Han were excluded.…”
Purpose
Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) are associated with polycythemia. However, there still remain unanswered questions about the relationship between overlap syndrome (OVS), where OSA and COPD coexist, and polycythemia. Here, we aimed to establish the prevalence of polycythemia in OVS patients and to explore the impact of OSA on polycythemia.
Patients and Methods
Patients with COPD underwent overnight polysomnography (PSG), pulmonary function tests, echocardiography, and complete blood counts. All patients were ethnic Han Chinese and free of prolonged oral corticosteroid use, hematological system disease, severe systemic disease, and other sleep-disordered breathing. OVS was defined as COPD patients with an apnea–hypopnea index ≥15 events/h, and polycythemia was defined as an Hb >165 g/L in men and >160 g/L in women.
Results
Eight-hundred and eighty-six patients with COPD were included in the analysis. The prevalence of polycythemia was significantly higher in OVS patients than COPD-alone patients (6.4% vs 2.9%,
p
< 0.05). The prevalence of polycythemia increased with OSA severity (
χ
2
= 7.885,
p
= 0.007), but not in GOLD grade 3–4 COPD patients (
χ
2
= 0.190,
p
= 0.663). After adjusting for confounders, percentage of total sleep time with SaO
2
<90% (TS
90
) remained independently associated with an increased odds of polycythemia (OR 1.030, 95% CI 1.015–1.046) and, with an increase in TS
90
, the hemoglobin increased, especially in GOLD grade 1–2 patients (
p
< 0.05).
Conclusion
Patients with OVS have a higher prevalence of polycythemia than those with COPD alone, and TS
90
is an independent factor for polycythemia, especially in GOLD1-2 COPD patients.
“…4 Zhang et al found that 6.6% of COPD patients met the diagnostic criteria for polycythemia with a cutoff of Hb >165 g/L in males and >160 g/L in females and suggested that race and altitude have an impact on the prevalence of polycythemia. 20 In our study, the prevalence of polycythemia was only 3.9%, which might be because all our patients lived at high altitudes and ethnic groups other than Han were excluded.…”
Purpose
Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) are associated with polycythemia. However, there still remain unanswered questions about the relationship between overlap syndrome (OVS), where OSA and COPD coexist, and polycythemia. Here, we aimed to establish the prevalence of polycythemia in OVS patients and to explore the impact of OSA on polycythemia.
Patients and Methods
Patients with COPD underwent overnight polysomnography (PSG), pulmonary function tests, echocardiography, and complete blood counts. All patients were ethnic Han Chinese and free of prolonged oral corticosteroid use, hematological system disease, severe systemic disease, and other sleep-disordered breathing. OVS was defined as COPD patients with an apnea–hypopnea index ≥15 events/h, and polycythemia was defined as an Hb >165 g/L in men and >160 g/L in women.
Results
Eight-hundred and eighty-six patients with COPD were included in the analysis. The prevalence of polycythemia was significantly higher in OVS patients than COPD-alone patients (6.4% vs 2.9%,
p
< 0.05). The prevalence of polycythemia increased with OSA severity (
χ
2
= 7.885,
p
= 0.007), but not in GOLD grade 3–4 COPD patients (
χ
2
= 0.190,
p
= 0.663). After adjusting for confounders, percentage of total sleep time with SaO
2
<90% (TS
90
) remained independently associated with an increased odds of polycythemia (OR 1.030, 95% CI 1.015–1.046) and, with an increase in TS
90
, the hemoglobin increased, especially in GOLD grade 1–2 patients (
p
< 0.05).
Conclusion
Patients with OVS have a higher prevalence of polycythemia than those with COPD alone, and TS
90
is an independent factor for polycythemia, especially in GOLD1-2 COPD patients.
“…Previous studies have revealed that physiologic reaction to excitement, splenic contraction, or inflammatory response could increase reticulocyte numbers in non-anemic conditions [7][8][9]. In addition, there have been many studies about hypoxic RAA [6,[10][11][12]. Some studies have shown that patients with RAA have poorer prognosis [6,12].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, there have been many studies about hypoxic RAA [6,[10][11][12]. Some studies have shown that patients with RAA have poorer prognosis [6,12]. In light of the growing interest in RAA, the study of hypoxic RAA in specific diseases would be a substantial contribution to the field of veterinary medicine [7,13].…”
Myxomatous mitral valve disease (MMVD) is the most common heart disease in small breed dogs. Dogs with MMVD commonly show clinical signs of dyspnea due to cardiogenic pulmonary edema (CPE). Reticulocytosis in the absence of anemia (RAA) is a hematological finding in hypoxic conditions. We aimed to assess the prevalence of RAA in dogs with CPE due to MMVD, and evaluate whether RAA is reversible with amelioration of dyspnea. Twenty-nine client-owned dogs with CPE due to MMVD were included. Dogs who died within 6 weeks of the onset of CPE were included in the non-survival group, while the others comprised the survival group. Of the 21 dogs, RAA was observed in 17 dogs (80.9%). In the RAA group, the absolute reticulocyte count significantly decreased as CPE resolved (p < 0.001). The mean absolute reticulocyte count in the RAA group was 163.90 ± 50.77 on the first measurement and 78.84 ± 25.64 after resolution of CPE. In the RAA group, no significant differences in mean absolute reticulocyte count were observed between the survival and non-survival groups at either the first or second measurement. Our results indicate that RAA occurs in dogs with MMVD-related CPE and can resolve after resolution of CPE.
“… 19 , 29 However, although some patients with COPD presented with marked polycythemia, other COPD patients had no or only a mild concurrent increase in red blood cell parameters. 30 , 31 In our study, because CIPF dogs all were WHWTs, it is impossible to differentiate whether the lack of erythrocytosis was associated with the disease process itself or a breed‐related genetic response to hypoxemia.…”
Background: Prolonged tissue hypoxia caused by chronic pulmonary disease is commonly regarded as an important mechanism in the development of secondary polycythemia, but little clinical data are available to support this hypothesis.Objective: To study the prevalence and severity of erythrocytosis accompanying chronic hypoxic pulmonary disease in dogs.Animals: Forty-seven dogs with hypoxic chronic pulmonary disease, 27 dogs with nonhypoxic chronic pulmonary disease, and 60 healthy controls.Methods: Dogs with chronic pulmonary disease and chronic hypoxemia (partial pressure of arterial oxygen [PaO 2 ] < 80 mm Hg on at least 2 arterial blood gas measurements a minimum of 1 month apart) were identified retrospectively from patient records. Association between arterial oxygen and red blood cell parameters was analyzed using Pearson's correlation coefficients and multivariable linear regression analysis.Results: Red blood cell parameters measured at the end of the hypoxemia period were within the laboratory reference range in most dogs. In chronically hypoxemic dogs, hematocrit (Hct) was increased in 4/47 (8.5%; 95% confidence interval [CI], 0-17) dogs, erythrocyte count (Erytr) was increased in 12/47 (26%; 95%CI, dogs and hemoglobin concentration (Hb) was increased in 3/47 (6.4%; 95%CI, 0-14) dogs. No marked polycythemia (Hct ≥65%) was noted in any of the dogs. Red blood cell parameters were not associated with the severity of hypoxemia (correlation to
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.